Avidity Partners Management’s Keros Therapeutics KROS Stock Holding History

Avidity Partners Management’s Portfolio KROS Stock Details KROS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$3.32M	Sell
2024 Q3	$17M	Sell
2024 Q2	$15.7M	Buy
2024 Q1	$13.9M	Buy
2021 Q4	–	Sell
2021 Q3	$5.74M	Buy
2021 Q1	–	Sell
2020 Q4	$2.82M	Buy